Average Co-Inventor Count = 3.59
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ranbaxy Laboratories, Inc. (14 from 157 patents)
2. Other (1 from 832,718 patents)
15 patents:
1. 7592359 - Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
2. 7517905 - Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
3. 7501443 - Flavaxate derivatives as muscarinic receptor antagonists
4. 7488748 - 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
5. 7465751 - 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
6. 7410993 - 3,6-disubstituted azabicyclo [3.1.0] hexane deriviatives useful as muscarinic receptor antagonists
7. 7399779 - 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists
8. 7288562 - Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
9. 7265147 - 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
10. 7232835 - 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
11. 7037899 - Derivatives of monosaccharides as cell adhesion inhibitors
12. 7005422 - Derivatives of monosaccharides as cell adhesion inhibitors
13. 6914064 - 1,4-Disubstituted piperazine derivatives useful as uro-selective α1-adrenoceptor blockers
14. 6590085 - Derivatives of monosaccharides as cell adhesion inhibitors
15. 6420366 - 1-(4-arylpiperazin-1-yl)-&ohgr;-[N-(&agr;&ohgr;-dicarboximido)]-alkanes useful as uro-selective &agr;1-adrenoceptor blockers